5Selvin E M, arinpoulo S, Berkenblit G, et al. Meta 2A nalysis: Gly2eo sylated hemoglobin and cardiovascular disease in diabetes mellitus[J], Ann Intern M ed, 2004, 141 (6): 421.
6Delarnater A M. Clinical use of hemoglobin A1 c to improve diabetes management [ J ]. Clin Diabetes, 2006, 24 ( 1 ) : 628.
7Diabetes Control and Complications Trial Research Group. Effect of intensive diabetes treatment on the development and progression of long - term complications in adolescents with insulindependent diabetes mellitus[J]. J Pediatr, 1994, 125 (2) : 177.
8Stratton I M, Adler A I, Nen H A, et al. Association of giy- caemia with maerovascular complications of type 2 diabetes (UKPDS 35) :prospective observational study[J]. B M J, 2000, 32i(7258): 405.
9Gross J L, de Azevedo M J, Silveiro S P, et al. Diabetic nephropathy: diagnosis, prevention, and treatment[J]. Dia- betes Care, 2005, 28(1): 164.
4Selvin E, Marinpoulo S, Berkenblit G, et al. Meta-a- nalysis., glyeosylated hemoglobin and cardiovascular disease in diabetes mellitus[J]. Ann Intern Med, 2004,141 (6) : 421-431.
5Delamater AM. Clinical use of hemoglobin Ale to im- prove diabetes management[J]. Clin Diabetes, 2006, 24(1) :628.
6American Diabetes Association. Standards of medical care in diabetes-2010[J]. Diabetes Care 2010,33 (Sup- pl 1) :S11-S61.
7American Diabetes Association.Diagnosis and classification of diabetes mellitus[J].Diabetes Care,2010,33(4):62-69.
8Yang W, Lu J, Weng J, et al. Prevalence of diabetes among men and women in China[J]. N Engl J Med, 2010,362 (12) : 1090-1101.
9American Diabetes Association. Standards of medical care in diahetes-2010[ J]. Diabetes Care,2010,33 Suppl 1 : S11-S61.
10Hanas R, John G, International HbA1 (e) Consensus Co- mmittee. 2010 consensus statement on the worldwide stan- dardization of the hemoglobin A ( 1 e ) measurement [ J ]. Ann Clin Biochem,2010,47( Pt 4) :290-291.
